Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
Open Access
- 19 April 2023
- journal article
- research article
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 41, 100627
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablationCancer, 2016
- Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Clinical Oncology, 2016
- Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular CarcinomaJournal of Clinical Oncology, 2016
- Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical ApplicationsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisJournal of Clinical Oncology, 2016
- Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular CarcinomaJournal of Clinical Oncology, 2013
- Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver TransplantationAnnals of Surgical Oncology, 2008
- Outcomes Analysis for 280 Patients with Cholangiocarcinoma Treated with Liver Transplantation Over an 18-year PeriodJournal of Gastrointestinal Surgery, 2008
- Spanish Experience in Liver Transplantation for Hilar and Peripheral CholangiocarcinomaAnnals of Surgery, 2004
- Role of Liver Transplantation in Cancer TherapyAnnals of Surgery, 1985